Cargando…

A longitudinal study to assess the frequency and cost of antivascular endothelial therapy, and inequalities in access, in England between 2005 and 2015

OBJECTIVES: High-cost antivascular endothelial growth factor (anti-VEGF) medicines for eye disorders challenge ophthalmologists and policymakers to provide fair access for patients while minimising costs. We describe the growth in the use and costs of these medicines and measure inequalities in acce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hollingworth, William, Jones, Tim, Reeves, Barnaby C, Peto, Tunde
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Health Policy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665286/ https://www.ncbi.nlm.nih.gov/pubmed/29061629 http://dx.doi.org/10.1136/bmjopen-2017-018289

Ejemplares similares

Complexity in the new NHS: longitudinal case studies of CCGs in England
por: Checkland, Katherine, et al.
Publicado: (2016)

Commentary: Antivascular endothelial growth factor and retinopathy of prematurity
por: Dudani, Ajay Indur, et al.
Publicado: (2019)

Did government spending cuts to social care for older people lead to an increase in emergency hospital admissions? An ecological study, England 2005–2016
por: Seamer, Paul, et al.
Publicado: (2019)

NHS reforms in England: the implications for chemotherapy commissioning
por: Staines, Carolyn, et al.
Publicado: (2014)

Variability and performance of NHS England’s ‘reason to reside’ criteria in predicting hospital discharge in acute hospitals in England: a retrospective, observational cohort study
por: Sapey, Elizabeth, et al.
Publicado: (2022)

A cross-sectional study of all clinicians’ conflict of interest disclosures to NHS hospital employers in England 2015-2016
por: Feldman, Harriet Ruth, et al.
Publicado: (2018)

Use of antivascular endothelial growth factor for diabetic macular edema
por: Karim, Rushmia, et al.
Publicado: (2010)

Integrated mental health services in England: a policy paradox
por: England, Elizabeth, et al.
Publicado: (2005)

Ten years of jointly commissioning health and social care in England
por: Hudson, Bob
Publicado: (2011)

Policy change and policy dilemmas: interpreting the community services White Paper in England
por: Hudson, Bob
Publicado: (2006)

Assessing inequalities in geographical access to emergency medical services in metropolitan Lisbon: a cross-sectional and ecological study
por: Silva, Katielle Susane do Nascimento, et al.
Publicado: (2020)

Partnership working in England—where we are now and where we’ve come from
por: Glasby, Jon, et al.
Publicado: (2011)

A longitudinal study of independent scholar-published open access journals
por: Björk, Bo-Christer, et al.
Publicado: (2016)

Antivascular Endothelial Growth Factor Dosing Frequency and Visual Outcomes in Macular Edema Following Central Retinal Vein Occlusion
por: Modi, Yasha S., et al.
Publicado: (2021)

Trends in social determinants of child health and perinatal outcomes in European countries 2005–2015 by level of austerity imposed by governments: a repeat cross-sectional analysis of routinely available data
por: Rajmil, Luis, et al.
Publicado: (2018)

Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11
por: Wildiers, H, et al.
Publicado: (2003)

Antiangiogenic drugs in the management of ocular diseases: Focus on antivascular endothelial growth factor
por: Sassa, Yukio, et al.
Publicado: (2010)

The Use of Antivascular Endothelial Growth Factor Agents in the Perioperative Period in Diabetic Vitrectomy
por: Abu-Yaghi, Nakhleh E., et al.
Publicado: (2012)

Antivascular Endothelial Growth Factor Agents for Neovascular Age-Related Macular Degeneration
por: Zampros, Ilias, et al.
Publicado: (2012)

Resistance to antivascular endothelial growth factor treatment in age-related macular degeneration
por: Tranos, Paris, et al.
Publicado: (2013)

Promising Novel Treatment against Keloids: Antivascular Endothelial Growth Factor Agents
por: Abtahi-Naeini, Bahareh, et al.
Publicado: (2019)

Integrating care for people with mental illness: the Care Programme Approach in England and its implications for long-term conditions management
por: Goodwin, Nick, et al.
Publicado: (2010)

An Open Access future? Report from the eurocancercoms project
por: Kenney, R, et al.
Publicado: (2011)

Integrated policy making in England for adults with long-term neurological conditions (LTNCs): some preliminary findings from a scoping study
por: Bernard, Sylvia, et al.
Publicado: (2008)

Antivascular Therapy for Epithelial Ovarian Cancer
por: Duhoux, Francois P., et al.
Publicado: (2010)

Urban-rural disparity in the utilization of national community-based hypertension monitoring service—results from the China Health and Retirement Longitudinal Study, 2015
por: Song, Hongxun, et al.
Publicado: (2019)

Integrated Health and Social Care in England: Ten Years On
por: Miller, Robin, et al.
Publicado: (2021)

The future role of the GP Quality and Outcomes Framework in England
por: Majeed, Azeem, et al.
Publicado: (2023)

COVID-19: Risk of increase in smoking rates among England’s 6 million smokers and relapse among England’s 11 million ex-smokers
por: Patwardhan, Pooja
Publicado: (2020)

Will Cardiovascular Disease Prevention Widen Health Inequalities?
por: Capewell, Simon, et al.
Publicado: (2010)

Proposal for improving access to palliative care by enhancing primary care services in an upper middle-income country
por: Segarmurthy, Malar Velli, et al.
Publicado: (2023)

Induction of endothelial cell apoptosis by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid
por: Ching, L-M, et al.
Publicado: (2002)

The Effect of Antivascular Endothelial Growth Factor on the Development of Adhesion Formation in Laparotomized Rats: Experimental Study
por: Basbug, Murat, et al.
Publicado: (2011)

Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma
por: Mansour, Ahmad M., et al.
Publicado: (2014)

Clinical characteristics and antivascular endothelial growth factor effect of choroidal neovascularization in younger patients in Taiwan
por: Li, Yi-Hsuan, et al.
Publicado: (2015)

Commentary: Ziv-aflibercept: An alternative antivascular endothelial growth factor agent for polypoidal choroidal vasculopathy
por: Anshuman, Kumar, et al.
Publicado: (2019)

Antivascular endothelial growth factor‐A therapy: a novel personalized treatment approach for psoriasis
por: Luengas‐Martinez, Andrea, et al.
Publicado: (2022)

Treatment for Nontype 1 Retinopathy of Prematurity by Intravitreal Injection of Antivascular Endothelial Growth Factor Drugs
por: Zhang, Haitao, et al.
Publicado: (2022)

Economic inequality increases the number of hours worked and decreases work–life balance perceptions: longitudinal and experimental evidence
por: Filippi, Silvia, et al.
Publicado: (2023)

Revisiting the Design of Phase III Clinical Trials of Antimalarial Drugs for Uncomplicated Plasmodium falciparum Malaria
por: Borrmann, Steffen, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_d79k1rgafhmm165rv0ijsf42ee